Hidradenitis Suppurativa in Patients with Skin of Color: Emerging Therapies and Strategies for Effective Management
Hidradenitis suppurativa (HS) remains one of the most challenging chronic inflammatory diseases seen in dermatology. At the 2025 Skin Of Color Update conference in New York City, Dr. Tiffany Mayo led a case-based discussion on emerging therapies and management strategies for HS, with an emphasis on patients with skin of color.
HS affects between 0.1-4% of the population and is more common in …
Hidradenitis suppurativa (HS) remains one of the most challenging chronic inflammatory diseases seen in dermatology. At the 2025 Skin Of Color Update conference in New York City, Dr. Tiffany Mayo led a case-based discussion on emerging therapies and management strategies for HS, with an emphasis on patients with skin of color.
HS affects between 0.1-4% of the population and is more common in …
Dr. Mona Shahriari, associate clinical professor of dermatology at Yale University School of Medicine, encourages clinicians to broaden their psoriasis color palette. Next Steps in Derm, in partnership with Skin of Color Update, interviewed Dr. Shahriari, who outlined how to diagnose psoriasis in patients with darker skin tones. Learn the domains of psoriatic arthritis and how that knowledge can …
Vulvar dermatoses are commonly underdiagnosed in women with skin of color, and culture plays a role. Certain communities of color view vulvar concerns with shame or as evidence of moral impurity, leading women to delay seeking care. Structural and educational barriers can also influence how a woman obtains medical care for her vulvar concerns and even what she shares with the clinician. In additio …
Vogue wrote an article about the ‘Hollywood Dose’ – microdosing isotretinoin for clearer skin. The concept of a reduced dose was once popular among models and actors who were looking for a flawless, glowing look. Yet dermatologists say prescribing isotretinoin at levels lower than the traditional dose can be beneficial for some everyday acne patients, too. Low-dose isotretinoin offers fewer …
The burden of vitiligo is significant in patients with skin of color, which makes treatment breakthroughs more impactful. Dr. Pearl E. Grimes, chair of the Pigmentary Disorders Exchange Symposium, spoke with Next Steps in Derm, in partnership with Skin of Color Update, about breakthroughs in the treatment of vitiligo in patients with skin of color. Find out which therapies have enhanced results i …